Utilization of opportunistic cervical cancer screening in Nigeria
- PMID: 37530986
- DOI: 10.1007/s10552-023-01764-1
Utilization of opportunistic cervical cancer screening in Nigeria
Abstract
Background: While various interventions have been conducted to decrease cervical cancer's burden in Nigeria, no study has examined the trends in cervical cancer screening uptake over time. The present study sought to fill this gap in knowledge using data collected at Jos University Teaching Hospital (JUTH) in Nigeria.
Methods: Data collected continuously between 2006 and 2016 were analyzed to identify trends in screening uptake, changes in risk factors for cervical cancer, and to identify factors for women screened at Jos University Teaching Hospital (JUTH) in Jos, Nigeria. Categorical analyses and logistic regression models were used to describe patient characteristics by year, and to identify factors associated with repeated screening uptake.
Results: A total of 14,088 women who were screened between 2006 and 2016 were included in the database; 2,800 women had more than one screening visit. Overall, screening uptake differed significantly by year. On average women were first screened at age 38. About 2% of women screened were women living with HIV. Most women (86%) had normal pap smear at first screening, with the greatest decreased risk of abnormalities observed between 2011 and 2014. Odds of a follow-up screening after a normal result decreased significantly between 2008 and 2016 compared to women screened in 2006 and 2007. Finally, women living with HIV had increased odds of follow-up screening after having a normal pap smear.
Conclusions: These findings contribute to our understanding of the potential social and health system barriers to cervical cancer control in Nigeria. The findings may assist policy makers to design interventions to increase access and compliance to recommended screening schedules in this vulnerable population.
Keywords: Cervical cancer screening; Health-seeking behavior; Low-resource settings; Opportunistic screening; Pap smear.
© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
References
-
- Singh D, Vignat J, Lorenzoni V et al (2023) Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health 11(2):e197–e206. https://doi.org/10.1016/s2214-109x(22)00501-0 - DOI - PubMed
-
- National Cancer Institute (2022) SEER cancer stat facts: cervical cancer. National Cancer Institute, Bethesda. https://seer.cancer.gov/statfacts/html/cervix.html
-
- Curado MP (2019) Importance of hospital cancer registries in Africa. Ecancermedicalscience 13:948–948. https://doi.org/10.3332/ecancer.2019.948 - DOI - PubMed - PMC
-
- Jedy-Agba E, Joko WY, Liu B et al (2020) Trends in cervical cancer incidence in sub-Saharan Africa. Br J Cancer 123(1):148–154. https://doi.org/10.1038/s41416-020-0831-9 - DOI - PubMed - PMC
-
- Ginsburg O, Badwe R, Boyle P et al (2017) Changing global policy to deliver safe, equitable, and affordable care for women’s cancers. Lancet. https://doi.org/10.1016/S0140-6736(16)31393-9 - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous